US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.90

+2.642.80%

Post-market: 96.77-0.1261-0.13%19:30 EDT

Volume:3K

Turnover:284.08K

Market Cap:423.44M

PE:54.03

High:96.90

Open:94.43

Low:94.43

Close:94.25

52wk High:98.82

52wk Low:70.01

Shares:4.37M

Float Shares:4.37M

Volume Ratio:0.23

T/O Rate:0.07%

Dividend:1.33

Dividend Rate:1.37%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.71

PE(LYR):5.19

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

New precision medicine venture gives Syngenis added firepower

The West Australian

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement

Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi

Truist sees ‘significant positive readthrough’ for Maze from Vertex data

Maze jumps 25% to $27.99 after Vertex kidney disease data

Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease

Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR by -42.7% at Week 13 in AMKD with Modest Proteinuria

Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease

THOMSON REUTERS

Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity

THOMSON REUTERS

Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":96.8962,"timestamp":1791576000000,"preClose":94.2541,"halted":0,"volume":2945,"hourTrading":{"tag":"盘后","latestPrice":96.7701,"preClose":96.8962,"latestTime":"19:30 EDT","volume":7,"amount":677.6832,"timestamp":1791588606237,"change":-0.1261,"changeRate":-0.001301,"amplitude":0},"delay":0,"changeRate":0.028031671831782377,"floatShares":4370000,"shares":4370000,"eps":1.793292,"marketStatus":"Market Closed","change":2.6421,"latestTime":"10-09 16:00:00 EDT","open":94.43,"high":96.8962,"low":94.43,"amount":284075.90745,"amplitude":0.026165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":94.2541,"sharesOutstanding":3180000,"nav":94.23351,"aum":409915768.5,"dividendRate":0.013716,"bidAskSpread":0.002189,"postHourTrading":{"tag":"盘后","latestPrice":96.7701,"preClose":96.8962,"latestTime":"19:30 EDT","volume":7,"amount":677.6832,"timestamp":1791588606237,"change":-0.1261,"changeRate":-0.001301,"amplitude":0},"volumeRatio":0.227009940754514,"impliedVol":0.1917,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4370000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.227009940754514,"shares":4370000,"dividePrice":1.329,"high":96.8962,"amplitude":0.026165,"preClose":94.2541,"low":94.43,"week52Low":70.01,"pbRate":"1.71","psRate":"246.66","week52High":98.82,"institutionHeld":0.2552,"latestPrice":96.8962,"eps":1.793292,"divideRate":0.013716,"volume":2945,"delay":0,"ttmEps":1.793292,"open":94.43,"prevYearClose":82.15,"prevWeekClose":95.07,"prevMonthClose":97.2888,"prevQuarterClose":97.2888,"fiveDayClose":95.07,"twentyDayClose":92.91,"sixtyDayClose":91.0787},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PBE","amount":0.01867,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","IE0002141913.USD","IBB","LU0823416689.USD","IE00BJJMRZ35.SGD","BBH","LABU","XLV","LU2362541273.HKD","LU2417539215.USD","PBE","NKTR","XBI","IE00B894F039.SGD","HCSG","LU0109394709.USD","GNMX","LU1559883803.SGD","LU2089984988.USD","VRTX","LU0757428866.USD","SG9999001176.SGD","LU2362541513.USD","TBXU","BK4007","VERX","LU0061475181.USD","LU0417517546.SGD","LU2324357040.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","IBBQ","LU0432979614.USD","LU1069344957.HKD","LU1674673428.USD","BK4585","BK4023","LU0256863811.USD","LU1035775433.USD","LU2237438978.USD","IDNA","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","BK4533","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0823416689.USD","SGXZ57979304.SGD","IDNA","TBXU","XLV","LABU","DGX","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","VRTX","XBI","LU0823417737.USD","PBE","IE00B19Z3B42.SGD","FFTY","BK4567","SG9999001176.USD","LU0417517546.SGD","BK4139","LU0823417653.USD","BK4583","LU1815336091.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2506952097.USD","IE00BZ9MQY76.HKD","IE0002270589.USD","LU0234570918.USD","LU2506951875.HKD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU2456880835.USD","GNMX","LU1854103824.USD","IBBQ","VERX","LU0757428866.USD","IE0009355771.USD","LU0289739699.SGD","LU0109394709.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU2506952170.USD","HCSG","IE00BJJMRZ35.SGD","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669105916","title":"US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669105916","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669105916?lang=en_us&edition=fundamental","pubTime":"2026-09-23 15:36","pubTimestamp":1790149013,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP- Allstate, Autozone, Vertex PharmaceuticalsSept 23 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Allst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4N45F0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCA","CRMD","DFEN","CWVX","CIFR","AZO","GPK","AMGN","CMI","CYH","PBE","CCL","AMRX","GE","GRDN","EXI","HII","ALLY","AXP","BSVN","PKB","CFG","BDC","ACHC","NATO","CLDX","BLCK","SHLD","WFRD","DCH","ARDT","ANIX","CMPX","GD","STZ","CRWV","ALL","ANAB","APLD","AMRZ","CRWG","FITB","CORZ","HBAN","HUT","CBZ","COLL","FOXA","HUTG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","TBXU","IE00B19Z9P08.USD","LU0889565916.HKD","IE0002141913.USD","PBE","LU1585245621.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IDNA","VRTX","BBH","LU1674673428.USD","BK4567","LU2462157665.USD","LU0061475181.USD","LU0109394709.USD","LU1035775433.USD","LU0234570918.USD","LU1069344957.HKD","LU1778281490.HKD","IE00B2B36J28.USD","SG9999001176.USD","LU1093756325.SGD","LU0058720904.USD","IBB","BK4585","LU2456880835.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU2417539215.USD","BIB","LU0432979614.USD","LU1093756168.USD","BK4588","LU2362540622.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4139","IE0002270589.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","IE00B19Z9Z06.USD","GNMX","LU2237438978.USD","SGXZ57979304.SGD","IE0009355771.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669577122","title":"Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669577122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669577122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:17","pubTimestamp":1790108275,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA salesOverviewUS pharmaceutical firm's fiscal Q4 revenue rose 6.4%, beating analyst expectationsCompany reported near break-even net loss for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4533","PBE","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2112291526.USD","BK4566","LU0289739699.SGD","LU1571399168.USD","LU2468319806.SGD","AYTU","LU2089984988.USD","LU0868494617.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","SG9999001440.SGD","BK4585","IE0002141913.USD","LU1061106388.HKD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","BK4007","BK4534","LU2242646821.SGD","LU0058720904.USD","LU0889565916.HKD","AMGN","BIB","IE00BJT1NW94.SGD","BK4599","BBH","BK4588","LU1983299246.USD","LU2242652126.USD","BK4581","LU1023059063.AUD","TBXU","IBBQ","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0002141913.USD","XBI","LU0079474960.USD","LU1778281490.HKD","IE00B894F039.SGD","IE00BJT1NW94.SGD","GNMX","IBB","LU0234570918.USD","BK4532","BK4567","LU0889565916.HKD","LU2089984988.USD","BK4023","LU1430594728.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4585","TBXU","IBBQ","LU1069344957.HKD","LU2462157665.USD","LU1815336091.USD","LU2324357040.USD","LU1559883803.SGD","LU2236285917.USD","LU1585245621.USD","IE00B19Z9Z06.USD","IDNA","IE00B2B36J28.USD","VERX","PBE","LU1674673428.USD","LU0256863811.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","BBH","LU2456880835.USD","LU1035775433.USD","MAZE","LU1093756168.USD","LU2362541513.USD","LU0432979614.USD","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","VRTX","LU2237438978.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669175122","title":"New precision medicine venture gives Syngenis added firepower","url":"https://stock-news.laohu8.com/highlight/detail?id=2669175122","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669175122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:27","pubTimestamp":1790094446,"startTime":"0","endTime":"0","summary":"Syngenis has joined the renowned Perron Institute and Gene S founders in a precision-medicine venture that puts its integrated DNA and RNA platform to work and opens the door to recurring manufacturing revenue.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-22912933/bcb694b9b6d3ad9e7ac40e225d21b3d9b69e7435.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22912933/bcb694b9b6d3ad9e7ac40e225d21b3d9b69e7435.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/new-precision-medicine-venture-gives-syngenis-added-firepower-c-22912933","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/new-precision-medicine-venture-gives-syngenis-added-firepower-c-22912933","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["TMAT","IIGF.AU","ZYAU.AU","FDIF","GIVE.AU","EES","IBB","HELX","E200.AU","IDNA","OZF.AU","EIGA.AU","VAS.AU","GNOM","HTEC","GEAR.AU","JDOC","IMLC.AU","BMED","SLF.AU","QRE.AU","DACE.AU","WDNA","IISV.AU","GNMX","XKO.AU","BBOZ.AU","GDOC","VAP.AU","IOZ.AU","BEAR.AU","SYNB","BK4588","XJO.AU","STW.AU","ADHD","PBE","XAO.AU","LFSC","OZR.AU","BK4585","XT","MEDX","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","LABU","OZEM","IBBQ","IE0009355771.USD","LU0128526141.USD","BK4566","LU2242646821.SGD","PBE","THNR","IE00BJT1NW94.SGD","XBI","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","AMGN","BK4534","LU0029874061.USD","LU1057294990.SGD","LU1571399168.USD","LU0868494617.USD","HCSG","LU0320765992.SGD","LU0058720904.USD","LU2089984988.USD","BK4599","LU0889565916.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","XLV","IE00BFTCPJ56.SGD","PJP","IE00B4R5TH58.HKD","VKTX","BK4137","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","ELDN","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123184","title":"Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123184","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123184?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:15","pubTimestamp":1790090123,"startTime":"0","endTime":"0","summary":"• Amgen shares rose following positive Phase 3 OASIZ 301 trial results for dazodalibep.  \n• The company reported an annual revenue of $36.75B and a net profit of $7.71B.  \n• Analysts hold an average price target of $389.14 with a Hold rating.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262180812-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4139","LU0289739699.SGD","LU0109394709.USD","LU1061106388.HKD","LU2242652126.USD","BBH","LU0122379950.USD","04332","BK4599","PBE","IBBQ","LU2089984988.USD","AMGN","LU0889565916.HKD","LU1571399168.USD","BK4566","IE00BJT1NW94.SGD","BIB","BK4588","LU2242646821.SGD","PJP","LU0868494617.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","TBXU","BK4533","LU0320765992.SGD","LU1023059063.AUD","IBB","IE0009355771.USD","LU1983299246.USD","BK4585","BK4581","LU2112291526.USD","SG9999001440.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669821123","title":"Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669821123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669821123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:55","pubTimestamp":1790088920,"startTime":"0","endTime":"0","summary":"Citi says Amgen’s (AMGN) dazodalibep delivered “positive” Phase 3 results in systemic Sjogren’s, which reduces clinical risk for “a potentially und...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","AMGN","BBH","IBBQ","BK4585","LU1061106388.HKD","LU0058720904.USD","LU2112291526.USD","LU2242652126.USD","LU0109394709.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4139","IE00B2B36J28.USD","LU0868494617.USD","PBE","BK4588","IE0009355771.USD","BK4581","LU0889565916.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","BIB","LU0289739699.SGD","IBB","LU1571399168.USD","BK4533","LU1057294990.SGD","BK4599","BK4566","LU0320765992.SGD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","BK4534","IE00BFTCPJ56.SGD","LU0122379950.USD","PJP","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128999","title":"Truist sees ‘significant positive readthrough’ for Maze from Vertex data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128999","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128999?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:30","pubTimestamp":1790087413,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill views Vertex’s (VRTX) positive Phase 2 topline data as a meaningful validation of APOL1 inhibition in classic APOL1-m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU1093756325.SGD","IE00BZ9MQY76.HKD","BBH","LU2456880835.USD","IBBQ","BK4585","LU2362541513.USD","LU0058720904.USD","LU1674673691.USD","LU1093756168.USD","IE00B4R5TH58.HKD","LU0061475181.USD","LU1069344957.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4532","LU0256863811.USD","GNMX","LU0757428866.USD","PBE","LU0079474960.USD","IE0009355771.USD","SGXZ57979304.SGD","LU0889565916.HKD","LU2362540622.SGD","LU1585245621.USD","IE0002141913.USD","IE0002270589.USD","BIB","LU0823416689.USD","LU0289739699.SGD","IBB","IE00B19Z3B42.SGD","IE00B894F039.SGD","BK4533","LU2462157665.USD","LU1559883803.SGD","VRTX","VERX","LU1035775433.USD","IDNA","LU0320765992.SGD","SG9999013999.USD","BK4023","LU1674673428.USD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU1778281490.HKD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919128","title":"Maze jumps 25% to $27.99 after Vertex kidney disease data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919128","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:25","pubTimestamp":1790087125,"startTime":"0","endTime":"0","summary":"10:23 EDT Maze jumps 25% to $27.99 after Vertex kidney disease data Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRTX","GNMX","IE00B19Z9Z06.USD","LU0432979614.USD","IE00B894F039.SGD","LU1778281490.HKD","SG9999013999.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU2456880835.USD","IBBQ","LU1815336091.USD","LU1559883803.SGD","IE0009355771.USD","LU1585245621.USD","PBE","IE00BJT1NW94.SGD","LU2462157665.USD","IBB","LU0079474960.USD","LU2236285917.USD","BK4533","LU0109394709.USD","BK4585","BK4139","LU0234570918.USD","LU2089984988.USD","BK4567","LU0320765992.SGD","LU0058720904.USD","LU2417539215.USD","IDNA","LU1674673428.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU2362541513.USD","LU1093756325.SGD","LU2362541273.HKD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","VERX","LU0256863811.USD","LU0289739699.SGD","BIB","TBXU","BK4023","BBH","LU1093756168.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669470171","title":"Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669470171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669470171?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084894,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen rises after autoimmune drug meets late-stage trial goal** Shares of drugmaker AmgenAMGN.Orise 2.4% to $402.69** Co says its experimental drug, dazodalibep, for Sjogren's diseasemet the main goalof reducing disease activity in a late-stage trial** Sjogren's disease is an autoimmune disorder that causes dryness of the eyes, mouth and other parts of the body, along with fatigue and chronic pain** Drug showed a statistically significant and clinically meaningful improvement at week 48; most side effects were mild to moderate** Co plans to present detailed results at an upcoming medical meeting** Including session's move, AMGN up 23.1% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4581","LU1571399168.USD","LU2468319806.SGD","LU2242652126.USD","IE0009355771.USD","BIB","AMGN","IE00B4R5TH58.HKD","BK4585","BK4588","IBB","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","PBE","LU2242646821.SGD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","LU1061106388.HKD","PJP","BK4534","BK4566","BK4599","IE00BFTCPJ56.SGD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU0122379950.USD","LU1983299246.USD","LU2089984988.USD","BK4139","TBXU","LU0868494617.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147050","title":"Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147050","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147050?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:45","pubTimestamp":1790084715,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Amgen Inc::*AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026*AMGEN: DAZODALIBEP MEETS PRIMARY ENDPOI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcc0x9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0109394709.USD","LU0889565916.HKD","BK4533","IE00B2B36J28.USD","PBE","LU1571399168.USD","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4599","LU1983299246.USD","BK4534","BK4139","BK4588","IE0002141913.USD","BBH","IBB","BIB","LU2112291526.USD","AMGN","IBBQ","LU0289739699.SGD","BK4581","SG9999001440.SGD","PJP","TBXU","IE00BJT1NW94.SGD","LU2242652126.USD","BK4585","IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4566","LU1061106388.HKD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147177","title":"Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147177?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:36","pubTimestamp":1790084178,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","AMGN","BBH","IBBQ","BK4585","LU1061106388.HKD","LU0058720904.USD","LU2112291526.USD","LU2242652126.USD","LU0109394709.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4139","IE00B2B36J28.USD","LU0868494617.USD","PBE","BK4588","IE0009355771.USD","BK4581","LU0889565916.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","BIB","LU0289739699.SGD","IBB","LU1571399168.USD","BK4533","LU1057294990.SGD","BK4599","BK4566","LU0320765992.SGD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","BK4534","IE00BFTCPJ56.SGD","LU0122379950.USD","PJP","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414223","title":"Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669414223?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082271,"startTime":"0","endTime":"0","summary":"Amgen says Phase 3 trial shows dazodalibep cuts systemic disease activity in Sjgren’s diseaseAmgen reported positive topline Phase 3 results for dazodalibep in adults with moderate-to-severe systemic ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL63L4Jz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0058720904.USD","BK4566","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","IBB","SG9999001440.SGD","BK4139","AMGN","BK4581","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2112291526.USD","TBXU","BK4533","LU0868494617.USD","LU2089984988.USD","LU1571399168.USD","IBBQ","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK4534","BK4599","LU0289739699.SGD","IE0009355771.USD","PJP","BK4588","IE00B2B36J28.USD","LU1061106388.HKD","PBE","BBH","BK4585","LU1057294990.SGD","LU2242652126.USD","LU1983299246.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142464","title":"Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR by -42.7% at Week 13 in AMKD with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142464","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142464?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:02","pubTimestamp":1790082154,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Vertex Pharmaceuticals Incorporated::*VERTEX ANNOUNCES POSITIVE RESULTS FROM PHASE 2B AMPLIFIED STUDY OF INAXAPLIN IN ADDITIONAL POPULATIONS OF PEOPLE WITH APOL1-MEDIATED KIDNEY DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSD66vtCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","IE00B4R5TH58.HKD","BK4139","LU0289739699.SGD","BBH","LU0417517546.SGD","LU0256863811.USD","IE00B19Z9Z06.USD","LU0079474960.USD","IE00B894F039.SGD","PBE","SG9999001176.SGD","IDNA","IBBQ","LU2089984988.USD","LU0889565916.HKD","LU1674673691.USD","IE00BJT1NW94.SGD","BIB","IE00BZ9MQY76.HKD","LU1093756325.SGD","LU2362541513.USD","LU2417539215.USD","BK4588","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1035775433.USD","LU0432979614.USD","BK4532","IE0002141913.USD","GNMX","IE00B19Z9P08.USD","BK4567","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","TBXU","BK4533","LU0320765992.SGD","LU1093756168.USD","IBB","IE0009355771.USD","LU0061475181.USD","VRTX","LU2362541273.HKD","LU0234570918.USD","BK4585","LU0823416689.USD","LU2362540622.SGD","LU2236285917.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142967","title":"Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142967?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082029,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2089984988.USD","LU2242652126.USD","BK4566","LU0868494617.USD","BBH","LU1571399168.USD","BK4599","IE00BFTCPJ56.SGD","BIB","LU1983299246.USD","LU2112291526.USD","IBB","BK4585","BK4534","LU0058720904.USD","IE0002141913.USD","BK4533","BK4588","BK4581","LU0289739699.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","AMGN","IE0009355771.USD","LU0109394709.USD","LU0122379950.USD","LU2468319806.SGD","BK4139","LU1057294990.SGD","PJP","LU2242646821.SGD","TBXU","PBE","IBBQ","IE00BJT1NW94.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142945","title":"Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142945?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1571399168.USD","TBXU","IE00B4R5TH58.HKD","LU1061106388.HKD","IE0009355771.USD","LU2468319806.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","LU0889565916.HKD","LU2242652126.USD","BK4534","LU1023059063.AUD","LU0868494617.USD","PBE","BK4588","AMGN","BK4581","IBBQ","LU2112291526.USD","SG9999001440.SGD","LU0320765992.SGD","LU0058720904.USD","PJP","BIB","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4566","BK4139","LU0109394709.USD","BK4533","BBH","IE00BFTCPJ56.SGD","BK4599","LU0289739699.SGD","BK4585","IBB","LU2242646821.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142617","title":"Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142617?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BIB","LU2468319806.SGD","BK4534","AMGN","LU0122379950.USD","TBXU","LU0320765992.SGD","LU2089984988.USD","BK4581","BK4139","IE00BFTCPJ56.SGD","BK4566","BK4599","LU2242646821.SGD","LU2112291526.USD","LU0058720904.USD","BK4585","LU1057294990.SGD","BBH","LU1061106388.HKD","LU0889565916.HKD","LU0868494617.USD","IBBQ","IE00B4R5TH58.HKD","LU2242652126.USD","IE00BJT1NW94.SGD","PJP","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0109394709.USD","PBE","IE00B2B36J28.USD","BK4533","IBB","IE0002141913.USD","LU0289739699.SGD","SG9999001440.SGD","LU1023059063.AUD","LU1571399168.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}